Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02348 DAWNRAYS PHARMA

Closed Add to Porfolio
Key Financial Ratio (Fiscal Year: 12/2019)
Current 2.77X Oper Margin 34.9%
LT Debt/Equity 0.1% Net Margin 26.9%
Total Debt/Equity 10.9% Return on Equity 12.6%
Price/Book 0.70X Return on Assets 9.2%
(HKD 1.020) 2019-122018-122017-122016-122015-12
Net Profit (MHKD) 285.55346.09351.66296.92360.73
Net Profit Growth (%) -17.5-1.6+18.4-17.7+40.6
Earnings Per Share (HKD) 0.1810.2180.2210.1850.224
Earnings Per Share Growth (%) -16.9-1.0+19.2-17.5+40.8
Dividend Per Share (HKD) 0.0580.1500.0750.0650.075
P/E* (X) 5.634.674.635.514.55
Yield (%) 5.6914.717.356.377.35
Dividend Share (%) 31.9968.7434.0135.1433.44
Book NAV (HKD) 1.4551.3791.3671.1401.093
Auditors' Opinion UnqualifiedUnqualifiedUnqualifiedUnqualifiedUnqualified
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2020-11-23 20:40:40

Latest Result

(RMBMn) 2020-06 2019-06 Chg* (%) 2018-06
Cover Period (mths) 6 6 NA 6
Turnover 488.993 490.75 -0.4 496.927
Operating Result 171.865 192.47 -10.7 209.046
Associates -9.96 -5.514 +80.6 -3.468
Profit Before Taxation 161.905 186.956 -13.4 205.578
Taxation 34.353 36.54 -6.0 39.385
Profit /( Loss) After Taxation 127.552 150.416 -15.2 166.193
Minority Interests -2.139 0 N/A 0
Net Profit 129.691 150.416 -13.8 166.193
Earnings Per Share () 0.0917 0.1078 -14.9 0.1242
Dividend Per Share () 0.0150 0.0150 +0.0 0.0150
Announcement Date 2020-08-25 2019-08-27 NA 2018-08-23
* Annualised
Last Update Time: 2020-11-23 20:40:47
Back to Top